What long‑acting antidepressants are recommended and what are their typical starting and titration doses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Long-Acting Antidepressants: Recommended Agents and Dosing

For long-acting antidepressant therapy, fluoxetine stands out as the only SSRI with a very long half-life (allowing every-other-day dosing), while extended-release formulations of venlafaxine, bupropion, and mirtazapine provide once-daily dosing with improved tolerability compared to immediate-release preparations.

Primary Long-Acting Options

Fluoxetine (Prozac)

  • Starting dose: 10 mg every other morning 1
  • Target dose: 20 mg every morning 1
  • Key characteristics: Very long half-life makes it the most "forgiving" SSRI for missed doses; activating properties; side effects may not manifest for several weeks due to prolonged half-life 1
  • Titration: Can increase at 3-4 week intervals due to long half-life 2

Venlafaxine Extended-Release

  • Starting dose: 37.5 mg once or twice daily 3
  • Titration: Increase by 75 mg each week 3
  • Target dose: 150-225 mg/day 3
  • Maximum: 225 mg/day 3
  • Duration for adequate trial: 4-6 weeks 3
  • Caution: Requires tapering when discontinuing due to withdrawal syndrome; use cautiously in cardiac disease due to potential blood pressure increases and conduction abnormalities 3

Bupropion Extended-Release

  • Starting dose: 37.5 mg every morning 1
  • Titration: Increase by 37.5 mg every 3 days 1
  • Target dose: 150 mg twice daily 1
  • Maximum: 400 mg/day for sustained-release formulation 4
  • Key characteristics: Activating; no serotonergic effects; useful for patients with sexual dysfunction from other antidepressants; contraindicated in seizure disorders and agitated patients 1, 4
  • Timing: Give second dose before 3 PM to minimize insomnia 1

Mirtazapine

  • Starting dose: 7.5 mg at bedtime 1
  • Target dose: 30 mg at bedtime 1
  • Maximum: 45 mg at bedtime 5
  • Titration: Can increase every 1-2 weeks due to long half-life 4
  • Key characteristics: Sedating; promotes sleep, appetite, and weight gain; well tolerated; onset of action within 1-2 weeks 1, 4

Alternative Long-Acting SSRI Options

Sertraline (Zoloft)

  • Starting dose: 25-50 mg per day 1
  • Target dose: 50 mg daily (optimal dose for most patients) 6, 7
  • Maximum: 200 mg per day 1
  • Titration: Increase at 1-2 week intervals 2
  • Key characteristics: Well tolerated; less effect on drug metabolism compared to other SSRIs; 50 mg is usually the effective therapeutic dose without need for titration 6, 8

Citalopram (Celexa)

  • Starting dose: 10 mg per day 1
  • Maximum: 40 mg per day 1
  • Titration: Increase at 1-2 week intervals 2
  • Critical warning: Do NOT exceed 40 mg/day due to QT prolongation risk and potential for Torsade de Pointes 2
  • Key characteristics: Well tolerated; least effect on CYP450 enzymes; lower drug interaction potential 2

Escitalopram (Lexapro)

  • Starting dose: 10 mg per day 9
  • Target dose: 10-20 mg per day
  • Key characteristics: Preferred in elderly patients; well tolerated 9

Critical Prescribing Considerations

Titration Strategy

  • Start low in elderly patients and titrate more slowly 3
  • Adequate trial duration: 4-8 weeks minimum, with at least 2 weeks at maximum tolerated dose 1
  • Monitor response: Assess within 1-2 weeks of initiation, then regularly 10
  • Modify treatment if inadequate response after 6-8 weeks 10

Common Pitfall

Most patients in clinical practice never receive the dose required for maximum antidepressant effect 11. For example, 54% of patients under 65 and 79% of patients over 65 never received doses shown to exert maximum efficacy (>20 mg citalopram, >10 mg escitalopram, >50 mg sertraline) 11. Don't undertitrate—push to effective doses unless limited by tolerability.

Discontinuation

  • Taper over 10-14 days to limit withdrawal symptoms 1
  • Paroxetine, fluvoxamine, sertraline, and venlafaxine have higher risk of discontinuation syndrome 2
  • Fluoxetine requires minimal tapering due to long half-life

Special Populations

Elderly patients: Prefer citalopram, escitalopram, sertraline, mirtazapine, venlafaxine, or bupropion; avoid paroxetine and fluoxetine due to higher adverse effect rates 9

Duration of Treatment

  • First episode: Minimum 4 months after remission 9
  • Recurrent depression: Consider prolonged or indefinite treatment 9

References

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Research

Other Antidepressants.

Handbook of experimental pharmacology, 2019

Research

Sertraline 50 mg daily: the optimal dose in the treatment of depression.

International clinical psychopharmacology, 1995

Research

SSRI efficacy-finding the right dose.

Journal of psychiatric practice, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.